Pancytopenia Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026


Transparency Market Research

$ 5795

Pancytopenia is a medical abnormality related to the blood, wherein the number of blood components, i.e., red blood corpuscles (RBC), white blood corpuscles (WBC), and platelets decline below normal limits. The condition could be life-threatening, if not treated. The condition is characterized by fever, chills, fatigue, weakness, breathlessness, lymph nodes swelling, and splenomegaly. 

The disease is classified into two types: idiopathic and secondary. The mechanism of idiopathic type is the inapprociate activation of T-cells due to autoimmune response, which leads to rapid hemophagocytic activity. The essential blood components, such as, RBC, WBC, and platelets are engulfed and destroyed at a rapid pace through the over-phagocytosis process. Pancytopenia further leads to a disease, called hemophagocytic lymphohistiocytosis (HLH). Major causes of pancytopenia include bone marrow suppression, heavy and long-term administration of drugs, such as antibiotics (e.g. chloramphenicol, linezolid), BP regulators, chemotherapeutic agents, other viral diseases such as HIV and hepatitis, and blood cancer. Diagnostic tests include complete blood count (CBC) and immunoassay. Treatments include immunosuppressant (cytophosphamide) and bone-marrow stimulators (epoetin alfa). 

In some mild cases of pancytopenia, treatment may not necessary. In moderate cases, transfusion of blood may restore blood cell counts; however, over a period of time, blood transfusions may become less effective. In severe cases of pancytopenia, stem cell therapy and bone marrow transplant technique may be used to restore the ability of bone marrow to develop blood cells. Normally, these techniques are quite effective in younger patients; however, older patients may also require this technique along with a combination of immunosuppressant drugs, which stimulate the bone marrow. 

The global pancytopenia market is anticipated to expand in the near future, owing to major drivers such as increased incidence rate of chronic diseases, rise in number of therapeutic products that suppress bone marrow activity and increased R&D practices and rise in awareness among the global population about blood-related disorders. According to estimates of Leukemia & Lymphoma Society (LLS), around 150,000 people in the U.S. are estimated to have been diagnosed with blood cancer, in 2013. Thus, high proportion of blood cancer patients is expected to boost the pancytopenia diagnostics and treatment market. However, high cost and long-term duration of therapy, side-effects associated with some treatment regime, and lack of reimbursement policies in developing countries are major restraints of the global pancytopenia market. 

The global pancytopenia market can be segmented based on diagnostic test, treatment, and end-user. Based on diagnostic test, the global pancytopenia market can be classified as complete blood count (CBC), immunoassay, and others. In terms of treatment, the global pancytopenia market can be segregated as immunosuppressant (cytophosphamide), bone-marrow stimulators (epoetin alfa), and others. Based on end-user, the global pancytopenia market can be segregated into hospitals, diagnostic centers, academic & research institutes, and others. By end users, Hospitals and diagnostic centers are anticipated to dominate the market in comeing years due to increase in number of hopistals and adopation of new technquies.

In terms of region, the global pancytopenia market can be split into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America leads the global pancytopenia market due to the presence of key players, technological advancements, and better infrastructure. The market in Asia Pacific is also expanding at a rapid pace. Key elements which drive the market in Asia Pacific include rise in global geriatric population, increase in number of blood-related disorders & infections, technological advancements in developing countries such as India, China, Japan, and government initiatives to support healthcare investments by key players in the region.

Some of the key players operating in the global pancytopenia market include Abbott Healthcare Pvt Ltd, Life Technologies Corporation, Roche Holding AG,  Beckman Coulter Inc., Bio-Rad Laboratories, Inc., and Ortho-Clinical Diagnostics.

MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.

The report provides the following information:

  • Tailwinds and headwinds molding the market’s trajectory
  • Market segments based on products, technology, and applications
  • Prospects of each segment
  • Overall current and possible future size of the market
  • Growth pace of the market
  • Competitive landscape and key players’ strategies

The main aim of the report is to:

  • Enable key stakeholder’s in the market bet right on it
  • Understand the opportunities and pitfalls awaiting them
  • Assess the overall growth scope in the near term
  • Strategize effectively with respect to production and distribution

MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.